Avai Bio (AVAI) notifies SEC of late FY2026 10-K, cites financial compilation

Rhea-AI Filing Summary

Avai Bio, Inc. filed a Form 12b-25 notifying the SEC that its Annual Report on Form 10-K for the fiscal year ended March 31, 2026 could not be filed on time because additional time is needed to complete preparation and compilation of the company's financial statements and related disclosures. The company states it expects to file the 10-K within the 15-calendar-day extension permitted under Rule 12b-25.

Contact for this notification is Vitalis Racius at the telephone number provided. The filing certifies that other periodic reports required during the preceding 12 months have been filed and that no significant change in results of operations versus the prior fiscal year is anticipated to be reported.

Key Figures

Fiscal period ended: March 31, 2026 Extension period: 15 calendar days Contact telephone: +1 540 495 0016 +1 more

4 metrics

Fiscal period ended March 31, 2026 Fiscal year end for the delayed Form 10-K

Extension period 15 calendar days Permitted under Rule 12b-25 for the annual report

Contact telephone +1 540 495 0016 Contact listed for the Form 12b-25 notification

Notification signature date June 30, 2026 Date the notification was signed by Vitalis Racius

Key Terms

Form 12b-25, Rule 12b-25(b), transition report

3 terms

Form 12b-25 regulatory

"Notification that the Annual Report on Form 10-K could not be filed within the prescribed time period"

Form 12b-25 is a notice a publicly traded company files with the U.S. Securities and Exchange Commission when it cannot deliver a required periodic report (like a quarterly or annual financial report) on time. It explains the reason for the delay and gives the company a short, temporary window to finish the report without being marked as delinquent; investors watch it because late filings can signal accounting, operational, or control issues that may affect a company’s reliability and stock risk, much like a missed homework deadline can raise concerns about a student’s preparedness.

Rule 12b-25(b) regulatory

"expects to file the annual report within the extension period of fifteen calendar days provided under Rule 12b-25"

transition report regulatory

"Check one: Transition Report on Form 10-K (box checked) in the header"

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 06/30/2026 - 07:20 AM Accepted by SEC EDGAR 06/30/2026 - 07:20 AM Learn about SEC filing dates

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 12b-25

NOTIFICATION OF LATE FILING

(Check one): 

[X] Form 10-K    [ ] Form 20-F  [ ] Form 11-K  [ ] Form 10-Q [ ] Form 10-D [ ] Form N-SAR [ ] Form N-CSR 

For Period Ended: March 31, 2026

[X] Transition Report on Form 10-K
[ ] Transition Report on Form 20-F
[ ] Transition Report on Form 11-K
[ ] Transition Report on Form 10-Q
[ ] Transition Report on Form N-SAR 

For the Transition Period Ended:

Nothing in this form shall be construed to imply that the Commission has verified any information contained herein.

If the notification relates to a portion of the filing checked above, identify the Item(s) to which the notification relates: 

PART I — REGISTRANT INFORMATION 

Avai Bio, Inc.

(formerly Avant Technologies, Inc., Trend Innovations Holding Inc. and FREECOOK)
Full Name of Registrant 

5348 Vegas Drive

Address of Principal Executive Office (Street and Number) 

Las Vegas, NV 89108

State and Zip Code 

PART II — RULES 12b-25(b) AND (c) 

If the subject report could not be filed without unreasonable effort or expense and the registrant seeks relief pursuant to Rule 12b-25(b), the following should be completed. (Check box if appropriate) 

[X] (a) The reason described in reasonable detail in Part III of this form could not be eliminated without unreasonable effort or expense 

(b) The subject annual report, semi-annual report, transition report on Form 10-K, Form 20-F, Form 11- K, Form N-SAR or Form N-CSR, or portion thereof, will be filed on or before the fifteenth calendar day following the prescribed due date; or the subject quarterly report or transition report on Form 10-Q, or subject distribution report on Form 10-D, or portion thereof, will be filed on or before the fifth calendar day following the prescribed due date; and

(c) The accountant’s statement or other exhibit required by Rule 12b-25(c) has been attached if applicable. 

PART III — NARRATIVE 

State below in reasonable detail why Forms 10-K or 10-KSB, 20-F, 11-K, 10-Q or 10-QSB, 10-D, N-SAR, N-CSR, or the transition report or portion thereof, could not be filed within the prescribed time period. 

The Annual Report on Form 10-K of Avai Bio, Inc. for the fiscal year ended March 31, 2026, could not be filed on schedule due to the additional time required to complete the preparation and compilation of the Registrant's financial statements and related disclosures. The Registrant expects to file the annual report within the extension period of fifteen calendar days provided under Rule 12b-25 of the Securities Exchange Act of 1934, as amended.

PART IV — OTHER INFORMATION 

(1) Name and telephone number of person to contact in regard to this notification 

Vitalis Racius

(Name)

+1

 (Area Code) 

T: 540 495 0016

(Telephone Number) 

(2) Have all other periodic reports required under Section 13 or 15(d) of the Securities Exchange Act of 1934 or Section 30 of the Investment Company Act of 1940 during the preceding 12 months or for such shorter period that the registrant was required to file such report(s) been filed? If answer is no, identify report(s). 

[X] Yes [ ] No 

(3) Is it anticipated that any significant change in results of operations from the corresponding period for the last fiscal year will be reflected by the earnings statements to be included in the subject report or portion thereof?

[ ] Yes [X] No 

If so, attach an explanation of the anticipated change, both narratively and quantitatively, and, if appropriate, state the reasons why a reasonable estimate of the results cannot be made. 

AVAI BIO, INC.

( Formerly AVANT TECHNOLOGIES, INC. ,

TREND INNOVATIONS HOLDING INC.

 and FREECOOK )

(Name of Registrant as Specified in Charter)

has caused this notification to be signed on its behalf by the undersigned hereunto duly authorized.

Date: June 30, 2026 By: /s/ Vitalis Racius

FAQ

Why did Avai Bio (AVAI) file a Form 12b-25?

The company filed Form 12b-25 because it needed additional time to complete preparation and compilation of its fiscal year 2026 financial statements and related disclosures. The notification explains the delay rather than reporting results.

When is Avai Bio expected to file its Form 10-K for fiscal year ended March 31, 2026?

Avai Bio expects to file the annual report within the 15-calendar-day extension allowed under Rule 12b-25. The notification states the company will use that extension to complete its financial statements and disclosures.

Does the Form 12b-25 say Avai Bio will report materially different results for fiscal 2026?

No. The filing indicates No significant change in results of operations is anticipated compared with the prior fiscal year. The company checked that no material change is expected to be reflected in the pending 10-K.

Who is the contact for the late filing notice from Avai Bio (AVAI)?

The contact listed is Vitalis Racius with telephone +1 540 495 0016. This person is named as the company contact for questions regarding the notification.